BR0108303A - Derivados do 1h-imidazopiridina - Google Patents

Derivados do 1h-imidazopiridina

Info

Publication number
BR0108303A
BR0108303A BR0108303-1A BR0108303A BR0108303A BR 0108303 A BR0108303 A BR 0108303A BR 0108303 A BR0108303 A BR 0108303A BR 0108303 A BR0108303 A BR 0108303A
Authority
BR
Brazil
Prior art keywords
group
imidazopyridine derivatives
alkyl group
containing heterocyclic
saturated nitrogen
Prior art date
Application number
BR0108303-1A
Other languages
English (en)
Inventor
Hideo Kato
Jun Sakaguchi
Tomoyuki Izumi
Ken-Ichi Kato
Original Assignee
Hokuriku Pharmaceutical
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hokuriku Pharmaceutical filed Critical Hokuriku Pharmaceutical
Publication of BR0108303A publication Critical patent/BR0108303A/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/4353—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/437—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems the heterocyclic ring system containing a five-membered ring having nitrogen as a ring hetero atom, e.g. indolizine, beta-carboline
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Abstract

"DERIVADOS DE 1H-IMIDAZOPIRIDINA". Ou um de seus sais que possuem ação inibidora contra a produção de uma citoquina, representados pela fórmula geral (I) a seguir: em que R^ 1^' representa um átomo de hidrogênio, um grupo alquila, um grupo cicloalquila ou um grupo arila; R^ 2^ representa um grupo cicloalquila, um grupo alquila, um grupo arila, grupo ciano, grupo mercapto, grupo carboxila ou grupo carbamoila; o anel A representa um anel homocíclico ou heterocíclico; R^ 3^ representa um grupo amino ou um grupo heterocíclico contendo nitrogênio saturado; e k representa um número inteiro de 0 a 3; desde que o composto em que R^ 3^ representa um grupo heterocíclico contendo nitrogênio saturado e R^ 2^ é um grupo alquila não substituído seja excluído.
BR0108303-1A 2000-02-09 2001-02-06 Derivados do 1h-imidazopiridina BR0108303A (pt)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP2000031270 2000-02-09
JP2000277507 2000-09-13
PCT/JP2001/000816 WO2001058900A1 (fr) 2000-02-09 2001-02-06 Derives de 1h-imidazopyridine

Publications (1)

Publication Number Publication Date
BR0108303A true BR0108303A (pt) 2003-03-05

Family

ID=26585077

Family Applications (1)

Application Number Title Priority Date Filing Date
BR0108303-1A BR0108303A (pt) 2000-02-09 2001-02-06 Derivados do 1h-imidazopiridina

Country Status (16)

Country Link
US (1) US20040054182A1 (pt)
EP (1) EP1256582A1 (pt)
KR (1) KR20020073211A (pt)
CN (1) CN1422269A (pt)
AU (1) AU2001230584A1 (pt)
BG (1) BG107067A (pt)
BR (1) BR0108303A (pt)
CA (1) CA2399136A1 (pt)
CZ (1) CZ20022626A3 (pt)
HU (1) HUP0204474A3 (pt)
IL (1) IL150841A0 (pt)
MX (1) MXPA02007525A (pt)
NO (1) NO20023750L (pt)
PL (1) PL355866A1 (pt)
SK (1) SK11202002A3 (pt)
WO (1) WO2001058900A1 (pt)

Families Citing this family (41)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1474425B9 (en) 2002-01-07 2008-07-02 Eisai Co., Ltd. Deazapurines and uses thereof
GB0211649D0 (en) 2002-05-21 2002-07-03 Novartis Ag Organic compounds
ES2282691T3 (es) * 2002-07-26 2007-10-16 Teva Gyogyszergyar Zartkoruen Mukodo Reszvenytarsasag Preparacion de ih-imidazo(4,5-c)quinolin-4-amina mediante nuevos int ermedios 1h-imidazo (4,5-c)quinolin-4-ciano y 1h-imidazo (4,5-c).
WO2004065380A1 (en) 2003-01-14 2004-08-05 Arena Pharmaceuticals Inc. 1,2,3-trisubstituted aryl and heteroaryl derivatives as modulators of metabolism and the prpphylaxis and treatment of disorders related thereto such as diabetes and hyperglycemia
EP1602655A4 (en) 2003-03-07 2010-06-09 Kowa Co BENZOFURAN DERIVATIVE
US7163947B2 (en) 2003-03-07 2007-01-16 3M Innovative Properties Company 1-Amino 1H-imidazoquinolines
AU2004220534A1 (en) * 2003-03-07 2004-09-23 3M Innovative Properties Company 1-amino 1H-imidazoquinolines
AR045260A1 (es) 2003-08-12 2005-10-19 3M Innovative Properties Co Compuestos que contienen imidazo-oxima sustituidos
AR045529A1 (es) 2003-08-27 2005-11-02 3M Innovative Properties Co Imidazoquinolinas sustituidas con grupos ariloxi o arilalquilenoxi
US20050054665A1 (en) 2003-09-05 2005-03-10 3M Innovative Properties Company Treatment for CD5+ B cell lymphoma
CN1897948A (zh) 2003-10-03 2007-01-17 3M创新有限公司 烷氧基取代的咪唑并喹啉
US7544697B2 (en) 2003-10-03 2009-06-09 Coley Pharmaceutical Group, Inc. Pyrazolopyridines and analogs thereof
EP1685129A4 (en) 2003-11-14 2008-10-22 3M Innovative Properties Co OXIMSUBSTITUTED IMIDAZORING CONNECTIONS
US8598192B2 (en) 2003-11-14 2013-12-03 3M Innovative Properties Company Hydroxylamine substituted imidazoquinolines
PL1687305T3 (pl) * 2003-11-21 2008-12-31 Novartis Ag Pochodne 1H-imidazochinolin jako inhibitory kinaz białkowych
AR046845A1 (es) * 2003-11-21 2005-12-28 Novartis Ag Derivados de 1h-imidazo[4,5-c]quinolina para tratamiento de enfermedades dependientes de las proteino-quinasas
JP4891088B2 (ja) 2003-11-25 2012-03-07 スリーエム イノベイティブ プロパティズ カンパニー 置換されたイミダゾ環系および方法
JP2007517035A (ja) 2003-12-29 2007-06-28 スリーエム イノベイティブ プロパティズ カンパニー アリールアルケニルおよびアリールアルキニル置換されたイミダゾキノリン
US8735421B2 (en) 2003-12-30 2014-05-27 3M Innovative Properties Company Imidazoquinolinyl sulfonamides
EP1730143A2 (en) 2004-03-24 2006-12-13 3M Innovative Properties Company Amide substituted imidazopyridines, imidazoquinolines, and imidazonaphthyridines
HUE026644T2 (en) 2004-05-28 2016-07-28 Oryxe Mixture for transdermal administration of low and high molecular weight compounds
WO2005123080A2 (en) 2004-06-15 2005-12-29 3M Innovative Properties Company Nitrogen-containing heterocyclyl substituted imidazoquinolines and imidazonaphthyridines
WO2006009826A1 (en) 2004-06-18 2006-01-26 3M Innovative Properties Company Aryloxy and arylalkyleneoxy substituted thiazoloquinolines and thiazolonaphthyridines
WO2006038923A2 (en) 2004-06-18 2006-04-13 3M Innovative Properties Company Aryl substituted imidazonaphthyridines
WO2006065280A2 (en) 2004-06-18 2006-06-22 3M Innovative Properties Company Isoxazole, dihydroisoxazole, and oxadiazole substituted imidazo ring compounds and methods
US8034938B2 (en) 2004-12-30 2011-10-11 3M Innovative Properties Company Substituted chiral fused [1,2]imidazo[4,5-c] ring compounds
EP1831226B1 (en) 2004-12-30 2012-08-08 3M Innovative Properties Company Chiral tetracyclic compounds inducing interferon biosynthesis
US7683171B2 (en) 2005-02-04 2010-03-23 Bristol-Myers Squibb Company 1H-imidazo[4,5-d]thieno[3,2-b]pyridine based tricyclic compounds and pharmaceutical compositions comprising same
WO2006084251A2 (en) 2005-02-04 2006-08-10 Coley Pharmaceutical Group, Inc. Aqueous gel formulations containing immune reponse modifiers
WO2006086634A2 (en) 2005-02-11 2006-08-17 Coley Pharmaceutical Group, Inc. Oxime and hydroxylamine substituted imidazo[4,5-c] ring compounds and methods
CA2602683A1 (en) 2005-04-01 2006-10-12 Coley Pharmaceutical Group, Inc. Pyrazolopyridine-1,4-diamines and analogs thereof
CA2602853A1 (en) * 2005-04-01 2006-11-16 Coley Pharmaceutical Group, Inc. Ring closing and related methods and intermediates
AU2006232375A1 (en) 2005-04-01 2006-10-12 Coley Pharmaceutical Group, Inc. 1-substituted pyrazolo (3,4-c) ring compounds as modulators of cytokine biosynthesis for the treatment of viral infections and neoplastic diseases
WO2007035935A1 (en) * 2005-09-23 2007-03-29 Coley Pharmaceutical Group, Inc. METHOD FOR 1H-IMIDAZO[4,5-c]PYRIDINES AND ANALOGS THEREOF
US7906506B2 (en) 2006-07-12 2011-03-15 3M Innovative Properties Company Substituted chiral fused [1,2] imidazo [4,5-c] ring compounds and methods
PE20131371A1 (es) 2010-09-22 2013-11-25 Arena Pharm Inc Moduladores del receptor gpr119 y el tratamiento de trastornos relacionados con este
KR20230151072A (ko) 2015-01-06 2023-10-31 아레나 파마슈티칼스, 인크. S1p1 수용체와 관련된 상태의 치료 방법
CA3002551A1 (en) 2015-06-22 2016-12-29 Arena Pharmaceuticals, Inc. Crystalline l-arginine salt of (r)-2-(7-(4-cyclopentyl-3-(trifluoromethyl)benzyloxy)-1,2,3,4-tetrahydrocyclo-penta[b]indol-3-yl)acetic acid(com pound 1)for use in s1p1 receptor-associated disorders
KR20180053318A (ko) 2015-09-17 2018-05-21 제이알엑스 바이오테크놀로지, 인코포레이티드 피부 수화 또는 보습을 향상시키기 위한 접근법
MA47504A (fr) 2017-02-16 2019-12-25 Arena Pharm Inc Composés et méthodes de traitement de l'angiocholite biliaire primitive
JP2020514343A (ja) * 2017-03-10 2020-05-21 ファイザー・インク 環状置換イミダゾ［４，５−ｃ］キノリン誘導体

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT998979B (it) * 1973-10-26 1976-02-20 Snam Progetti Processo per la preparazione di chelati di uranio iv
US4293547A (en) * 1980-08-25 1981-10-06 The Upjohn Company Method of treating malaria
US6001355A (en) * 1982-12-14 1999-12-14 Dowdle; Eugene Bernard Davey Pro-tPA for the treatment of thrombosis, embolism and related conditions
DE3665609D1 (en) * 1985-05-28 1989-10-19 Sumitomo Chemical Co Recovery of metals adsorbed on chelating agents
GB8601421D0 (en) * 1986-01-21 1986-02-26 Welding Inst Charged particle beam generator
US4988815A (en) * 1989-10-26 1991-01-29 Riker Laboratories, Inc. 3-Amino or 3-nitro quinoline compounds which are intermediates in preparing 1H-imidazo[4,5-c]quinolines
US5175296A (en) * 1991-03-01 1992-12-29 Minnesota Mining And Manufacturing Company Imidazo[4,5-c]quinolin-4-amines and processes for their preparation
US5243041A (en) * 1991-08-22 1993-09-07 Fernandez Pol Jose A DNA vector with isolated CDNA gene encoding metallopanstimulin
US6140466A (en) * 1994-01-18 2000-10-31 The Scripps Research Institute Zinc finger protein derivatives and methods therefor
US5780455A (en) * 1994-08-24 1998-07-14 Merck & Co., Inc. Intravenous alendronate formulations
US5854215A (en) * 1995-03-14 1998-12-29 Praecis Pharmaceuticals Incorporated Modulators of β-amyloid peptide aggregation
US5668016A (en) * 1995-12-29 1997-09-16 Fernandez-Pol; Jose Alberto Method of preparing and activating samples for radioimmunoassay and other test
US5767135A (en) * 1995-12-29 1998-06-16 Fernandez-Pol; Jose Alberto Antiviral agent
US5955287A (en) * 1995-12-29 1999-09-21 Fernandez-Pol; Jose Alberto Method of determining level of biological substances elevated in the presence of cancer and other neoplasms
US6127393A (en) * 1995-12-29 2000-10-03 Novactyl, Inc. Antiproliferative, antiinfective, antiinflammatory, autologous immunization agent and method
ES2162319T3 (es) * 1996-08-13 2001-12-16 Gerolymatos P N Sa Uso del agente quelante clioquinol para la fabricacion de una composicion farmaceutica para el tratamiento de la enfermedad de alzheimer.
JP2000119271A (ja) * 1998-08-12 2000-04-25 Hokuriku Seiyaku Co Ltd １ｈ―イミダゾピリジン誘導体

Also Published As

Publication number Publication date
AU2001230584A1 (en) 2001-08-20
CN1422269A (zh) 2003-06-04
CA2399136A1 (en) 2001-08-16
CZ20022626A3 (cs) 2003-02-12
HUP0204474A2 (hu) 2003-04-28
KR20020073211A (ko) 2002-09-19
HUP0204474A3 (en) 2004-07-28
SK11202002A3 (sk) 2003-03-04
IL150841A0 (en) 2003-02-12
WO2001058900A1 (fr) 2001-08-16
MXPA02007525A (es) 2002-12-13
BG107067A (bg) 2003-09-30
NO20023750L (no) 2002-10-07
US20040054182A1 (en) 2004-03-18
EP1256582A1 (en) 2002-11-13
PL355866A1 (en) 2004-05-31
NO20023750D0 (no) 2002-08-08

Similar Documents

Publication Publication Date Title
BR0108303A (pt) Derivados do 1h-imidazopiridina
BR0014526A (pt) Compostos cìclicos de seis elementos contendo nitrogênio aromático
TW200602322A (en) Phosphodiesterase 4 inhibitors, including n-substituted diarylamine analogs
ATE417038T1 (de) Phenylpyridincarbonyl piperazinderivate
ID28806A (id) Turunan-turunan karboksamida heterosiklik yang mengandung nitrogen atau garam-garam daripadanya dan zat-zat antivirus yang terdiri dari senyawa ini
ATE449099T1 (de) Derivate des 2-trifluormethyl-6-aminopurins als phosphodiesterase 4 inhibitoren
BR0014541A (pt) Compostos quìmicos
BR0311697A (pt) Novos derivados condensados de imidazol
AR039665A1 (es) Fenilacetamidas sustituidas y su uso como activadores de glucoquinasa
BRPI0413991A (pt) composto ativador de ppar e composição farmacêutica contendo o mesmo
HRP20070286T3 (en) Substituted diketopiperazines and their use as oxytocyn antagonists
DK1008592T3 (da) Cykliske amidderivater, som inhiberer cathepsin K
ATE150964T1 (de) Restenosehemmer nach perkutaner koronarer arterioplastie
BR9913405A (pt) Composto heterocìclico que contenha oxigênio, e, inibidor de fosfodiesterase (pde) iv.
NO20050871L (no) 6-amino-1H-indazol- og 4-aminobenzofuranforbindelser som fosfodiesterase 4-inhibitorer
EA200401470A1 (ru) Производные пиперазинилацилпиперидина, их получение и их терапевтическое применение
BR0309558A (pt) Derivados de quinazolina e medicamentos
DE69824450D1 (de) Biphenylamidin-derivate
MY137964A (en) Benzofuran derivative
BR0307424A (pt) Compostos heterocìclicos com atividade inibidora de elastase e seus intermediários
EA200600608A1 (ru) Производные имидазопиридина как ингибиторы индуцируемой no-синтазы
EA200300010A1 (ru) Производные 2-аминотиазолина и их применение в качестве ингибиторов no-синтазы
BR0308935A (pt) Inibidor de fosfodiesterase iv contendo derivado de piridilacrilamida
ES2189736T3 (es) Derivados de la benzamida y medicamentos que los contienen.
NO20050764L (no) Forbindelser

Legal Events

Date Code Title Description
B11A Dismissal acc. art.33 of ipl - examination not requested within 36 months of filing
B11Y Definitive dismissal - extension of time limit for request of examination expired [chapter 11.1.1 patent gazette]